Assistant Professor, Faculty of Medicine, McGill University.
Director of the Interdisciplinary Memory Clinic, CHU of Quebec-Laval Univeristy, l’Enfant-Jésus Hospital.
In the early 70s, Dr. Bouchard founded the Quebec Interdisciplinary Memory Clinic (CIME), the oldest memory clinic in Canada. Over the years, he has assembled a team of nine specialist physicians, representing cognitive neurology, geriatrics, neuropsychiatry and geriatric psychiatry. After studying medicine and obtaining a master’s degree in neurobiology from Laval University, Dr. Bouchard completed a training in Cognitive and Behavioral Neurology at Boston City Hospital at Harvard University under the supervision of Prof. Norman Geschwind, followed by a fellowship at the hospital of La Salpêtrière de Paris under the supervision of Professor François Lhermitte. Dr. Bouchard is recognized by his peers as a pioneer in the field of cognitive neurology. The Quebec network of memory clinics and the organizing committee of the first Quebec congress on Alzheimer’s disease created in 2012 the “Rémi W Bouchard” award, presented at each conference for the next generation of scientists. He is also recognized nationally for his outstanding contribution to the understanding and treatment of patients with cognitive impairment, by receiving the “Irma M. Parhad Award” in 2014. At the request of the international journal Lancet Neurology, which publishes career profiles, colleagues at the Memory Clinic summarized his career profile, which was published in May 2017. He was recently honored by the Canadian Medical Association in Montreal. He co-founded the Alzheimer Society of Quebec 32 years ago, and is currently a member of its board of executives. He is also a member of the C5R, the Canadian Society of Neurology, and of the FRSQ research centre of the CHU of Quebec at l’Enfant-Jésus Hospital. He is a member of the executive of the Quebec congress on Alzheimer’s disease. Being responsible for a large number of conferences to the general public, he has always been very involved at the socio-community and humanitarian levels.
For more than 45 years, Dr. Bouchard has been actively involved in teaching cognitive neurology (over 415 courses or conferences). In research, he has been particularly interested in the clinical profile, early diagnosis, and treatment of neurodegenerative diseases, mainly Alzheimer’s disease. He has participated in numerous therapeutic clinical trials in collaboration with the international scientific community. He is the author or co-author of over 125 scientific or abstract publications, as well as of several book chapters in the cognitive or cerebrovascular field. He works closely with other CIME members on a variety of clinical, epidemiological, therapeutic, genetic and imaging research projects in the field of neurodegenerative diseases.
Canada G1J 1Z4
Data not available
Validation of the Dépistage Cognitif de Québec: A New Cognitive Screening Tool for Atypical Dementias.Journal Article
Arch Clin Neuropsychol, 33 (1), pp. 57-65, 2018, ISSN: 0887-6177.
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.Journal Article
Ann Neurol, 84 (5), pp. 729-740, 2018, ISSN: 0364-5134.
The Dépistage Cognitif de Québec: A New Clinician's Tool for Early Recognition of Atypical Dementia.Journal Article
Dement Geriatr Cogn Disord, 46 (5-6), pp. 310-321, 2018, ISSN: 1420-8008.
Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults.Journal Article
CMAJ, 189 (48), pp. E1472-E1480, 2017, ISSN: 0820-3946.
Multicenter Validation of an MMSE-MoCA Conversion Table.Journal Article
J Am Geriatr Soc, 65 (5), pp. 1067-1072, 2017, ISSN: 0002-8614.
Finger-to-Nose Test Findings in Alzheimer's Disease.Journal Article
J Alzheimers Dis, 55 (4), pp. 1335-1337, 2017, ISSN: 1387-2877.
Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.Journal Article
J Alzheimers Dis, 52 (4), pp. 1251-62, 2016, ISSN: 1387-2877.
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.Journal Article
Neurology (ECronicon), 2 (6), pp. 278-286, 2016.
Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.Journal Article
J Alzheimers Dis, 49 (3), pp. 695-705, 2016, ISSN: 1387-2877.
Semantic memory impairment for biological and man-made objects in individuals with amnestic mild cognitive impairment or late-life depression.Journal Article
J Geriatr Psychiatry Neurol, 28 (2), pp. 108-16, 2015, ISSN: 0891-9887.